Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 11, 2001
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone
G Egerer, U Hegenbart, H Salwender, et al.
Bone Marrow Transplantation
|
June 18, 1999
Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
K Kiel, F W Cremer, C Rottenburger, et al.
Der Pathologe
|
April 10, 2009
[Risk stratification and treatment of cardiac amyloidoses]
A V Kristen, S O Schönland, A Remppis, et al.
Scandinavian Journal of Rheumatology
|
November 10, 2012
Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk
D Ebrahimi-Fakhari, S O Schönland, U Hegenbart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 4, 2003
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria
U Hegenbart, D Niederwieser, S Forman, et al.
British Journal of Haematology
|
March 2, 1999
Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content
M T Voso, S Hohaus, M Moos, et al.
Leukemia
|
July 9, 2004
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning
T Lange, M Deininger, R Brand, et al.
Bone Marrow Transplantation
|
August 31, 2004
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?
D Niederwieser, C Gentilini, U Hegenbart, et al.
Blood Cancer Journal
|
February 25, 2017
Mutational landscape reflects the biological continuum of plasma cell dyscrasias
A Rossi, M Voigtlaender, S Janjetovic, et al.
Bone Marrow Transplantation
|
January 16, 2008
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
M C Minnema, N W C J van de Donk, S Zweegman, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 11, 2001
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone
G Egerer, U Hegenbart, H Salwender, et al.
Bone Marrow Transplantation
|
June 18, 1999
Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
K Kiel, F W Cremer, C Rottenburger, et al.
Der Pathologe
|
April 10, 2009
[Risk stratification and treatment of cardiac amyloidoses]
A V Kristen, S O Schönland, A Remppis, et al.
Scandinavian Journal of Rheumatology
|
November 10, 2012
Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk
D Ebrahimi-Fakhari, S O Schönland, U Hegenbart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 4, 2003
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria
U Hegenbart, D Niederwieser, S Forman, et al.
British Journal of Haematology
|
March 2, 1999
Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content
M T Voso, S Hohaus, M Moos, et al.
Leukemia
|
July 9, 2004
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning
T Lange, M Deininger, R Brand, et al.
Bone Marrow Transplantation
|
August 31, 2004
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?
D Niederwieser, C Gentilini, U Hegenbart, et al.
Blood Cancer Journal
|
February 25, 2017
Mutational landscape reflects the biological continuum of plasma cell dyscrasias
A Rossi, M Voigtlaender, S Janjetovic, et al.
Bone Marrow Transplantation
|
January 16, 2008
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
M C Minnema, N W C J van de Donk, S Zweegman, et al.
Page
of 6